相关实验视频
Updated: May 27, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.5K
强大的p53表型和潜在的下游目标在以端粒酶不朽化的人类细胞中
Jessica J Miciak1,2, Lucy Petrova1, Rhythm Sajwan1
1Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.
Oncotarget
|February 19, 2025
概括
在癌细胞中恢复野生型p53阻碍了癌细胞的增殖,并增加了对辐射的敏感性. 在正常细胞中研究p53揭示了像ALDH3A1和NECTIN4这样的新目标,这对于理解瘤抑制至关重要.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 野生型TP53通常在癌症中丢失,阻碍了对其全面瘤抑制功能的研究.
- 通常使用的与野生型TP53的癌症模型可能不能完全代表p53的能力.
- 以前的模型,如HCT116结肠直肠癌 (CRC) 细胞,尽管是野生型TP53,但缺乏某些p53表型.
研究的目的:
- 调查恢复TP53-突变结直肠癌细胞中的野生型p53的功能影响.
- 在非癌细胞系 (hTERT-RPE1) 中探索p53依赖的表型,以了解p53的更广泛的作用.
- 确定在癌症中具有潜在临床意义的新型p53点基因.
主要方法:
- 在TP53-突变DLD-1CRC细胞系中恢复p53.
- 在永生hTERT-RPE1细胞中破坏TP53.
- 对p53依赖表型的分析,包括细胞增殖,衰老和对电离辐射 (IR) 的反应.
- 转录基因分析以确定p53响应基因.
主要成果:
- 在DLD-1细胞中恢复p53减少了增殖,诱导衰老,并增加了对IR的敏感性.
- 在hTERT-RPE1细胞中TP53的破坏揭示了显著的p53-依赖表型,这表明在培养过程中选择了p53损失.
- 在hTERT-RPE1细胞中确定了一个p53响应的转录组,作为各种实验系统的模型.
- 发现了新的p53标,包括ALDH3A1 (化物排毒,ROS代谢) 和NECTIN4 (细胞粘附,在瘤中过度表达).
结论:
- 野生类型的p53积极抑制瘤生长,增强治疗灵敏度.
- hTERT-RPE1细胞系是研究p53功能和识别新目标的有价值模型.
- ALDH3A1和NECTIN4是潜在的治疗点,因为它们在排毒,新陈代谢和瘤中普遍存在.
相关概念视频
Telomeres and Telomerase
23.0K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Replication in Eukaryotes
13.0K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
13.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

